Search research articles
Contact Us
Filters
Showing results (201-210 of 229) with videos related to
Page
of 23
Sort By:
European Urology
|
June 19, 2022
Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma
Andrew Chang, Nicholas H Chakiryan, Dongliang Du, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
October 25, 2011
Diagnostic and therapeutic approach of congenital solitary coronary artery fistulas in adults: Dutch case series and review of literature
S A M Said, R L G Nijhuis, J W Op den Akker, et al.
Cancer Discovery
|
December 28, 2014
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype
Kim H T Paraiso, Meghna Das Thakur, Bin Fang, et al.
Plos One
|
November 20, 2018
Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker
Jaileene Pérez-Morales, Darielys Mejías-Morales, Stephanie Rivera-Rivera, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease
Mariam Lotfy Khaled, Yuan Ren, Ronak Kundalia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2018
Combined BRAF and HSP90 Inhibition in Patients with Unresectable <i>BRAF</i> <sup>V600E</sup>-Mutant Melanoma
Zeynep Eroglu, Y Ann Chen, Geoffrey T Gibney, et al.
Cell Reports Methods
|
October 21, 2021
Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling
Jeffrey R Whiteaker, Kanika Sharma, Melissa A Hoffman, et al.
Journal of Proteome Research
|
May 20, 2021
Metabolic Changes Are Associated with Melphalan Resistance in Multiple Myeloma
David C Koomen, Mark B Meads, Dario M Magaletti, et al.
Proteomics. Clinical Applications
|
June 10, 2011
A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer
Elizabeth R Remily-Wood, Richard Z Liu, Yun Xiang, et al.
Cancer Research
|
October 30, 2025
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wildtype RAS Activation in Non-Small Cell Lung Cancer
Hitendra S Solanki, Harshit Shah, Denis Imbody, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 229) with videos related to
Sort By:
Page
of 23
European Urology
|
June 19, 2022
Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma
Andrew Chang, Nicholas H Chakiryan, Dongliang Du, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
October 25, 2011
Diagnostic and therapeutic approach of congenital solitary coronary artery fistulas in adults: Dutch case series and review of literature
S A M Said, R L G Nijhuis, J W Op den Akker, et al.
Cancer Discovery
|
December 28, 2014
Ligand-independent EPHA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype
Kim H T Paraiso, Meghna Das Thakur, Bin Fang, et al.
Plos One
|
November 20, 2018
Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker
Jaileene Pérez-Morales, Darielys Mejías-Morales, Stephanie Rivera-Rivera, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease
Mariam Lotfy Khaled, Yuan Ren, Ronak Kundalia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2018
Combined BRAF and HSP90 Inhibition in Patients with Unresectable <i>BRAF</i> <sup>V600E</sup>-Mutant Melanoma
Zeynep Eroglu, Y Ann Chen, Geoffrey T Gibney, et al.
Cell Reports Methods
|
October 21, 2021
Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling
Jeffrey R Whiteaker, Kanika Sharma, Melissa A Hoffman, et al.
Journal of Proteome Research
|
May 20, 2021
Metabolic Changes Are Associated with Melphalan Resistance in Multiple Myeloma
David C Koomen, Mark B Meads, Dario M Magaletti, et al.
Proteomics. Clinical Applications
|
June 10, 2011
A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer
Elizabeth R Remily-Wood, Richard Z Liu, Yun Xiang, et al.
Cancer Research
|
October 30, 2025
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wildtype RAS Activation in Non-Small Cell Lung Cancer
Hitendra S Solanki, Harshit Shah, Denis Imbody, et al.
Page
of 23